Vitamin K Antagonist [EPC]

Known as: Vitamin K Antagonist 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
012320112017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Effective stroke prevention in patients with atrial fibrillation (AF) means using oral anticoagulation (OAC) therapy, which… (More)
Is this relevant?
2015
2015
BACKGROUND AND PURPOSE Although recommended by guidelines, the benefits of treating patients with atrial fibrillation with a low… (More)
Is this relevant?
2015
2015
BACKGROUND The AVERROES trial name is the following: The Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial… (More)
Is this relevant?
2014
2014
BACKGROUND AND PURPOSE The main objective of the present analysis was to assess the effect of treatment with aspirin compared… (More)
  • table II
Is this relevant?
Review
2013
Review
2013
The fact that the patient experienced intermittent palpitations, has an infarct on imaging suggesting an embolic pattern, and has… (More)
Is this relevant?
2012
2012
BACKGROUND Apixaban is superior to aspirin for the prevention of stroke in patients with atrial fibrillation. Apixaban is… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2011
Review
2011
The objective of this review is to summarize data from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Background—Vitamin K antagonist (VKA) therapy is increasingly being used for the prevention of venous thromboembolism and stroke… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 6
Is this relevant?